Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
2022 · Nature Communications · 181 citations
https://doi.org/10.1038/s41467-022-31997-8
H
Huarui Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
34
Papers
702
Citations
12
h-index
12
i10-index
Huarui Zhang is an academic researcher from Chinese University of Hong Kong. The author has contributed to research in topics: Advanced biosensing and bioanalysis techniques & RNA Interference and Gene Delivery & Bone Metabolism and Diseases. The author has an h-index of 12, co-authored 29 publications.
ORCID: 0000-0001-5008-3447Papers by this author
worksUnderstanding parental self-medication with antibiotics among parents of different nationalities: a cross-sectional study
2021 · Global Health Research and Policy · 18 citations
https://doi.org/10.1186/s41256-021-00226-y
Unique quinoline orientations shape the modified aptamer to sclerostin for enhanced binding affinity and bone anabolic potential
2024 · Molecular Therapy — Nucleic Acids · 12 citations
https://doi.org/10.1016/j.omtn.2024.102146
A bimolecular modification strategy for developing long-lasting bone anabolic aptamer
2023 · Molecular Therapy — Nucleic Acids · 11 citations
https://doi.org/10.1016/j.omtn.2023.102073
Aptamer functionalized hypoxia-potentiating agent and hypoxia-inducible factor inhibitor combined with hypoxia-activated prodrug for enhanced tumor therapy
2024 · Cancer Letters · 9 citations
https://doi.org/10.1016/j.canlet.2024.217102
Author Correction: HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis
2020 · Nature Communications · 3 citations
https://doi.org/10.1038/s41467-020-16901-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat